Thermo Fisher Scientific Inc. (NYSE:TMO)’s share price reached a new 52-week high during mid-day trading on Wednesday . The stock traded as high as $155.17 and last traded at $154.68, with a volume of 401,869 shares. The stock had previously closed at $154.38.

Several equities analysts recently issued reports on the company. Goldman Sachs Group Inc. reissued a “buy” rating on shares of Thermo Fisher Scientific in a research note on Wednesday, July 6th. Leerink Swann reissued a “buy” rating on shares of Thermo Fisher Scientific in a research note on Sunday, May 29th. Mizuho increased their target price on Thermo Fisher Scientific from $166.00 to $170.00 and gave the stock a “buy” rating in a research note on Friday, May 27th. BTIG Research reissued a “neutral” rating on shares of Thermo Fisher Scientific in a research note on Friday, May 27th. Finally, Morgan Stanley reissued a “buy” rating on shares of Thermo Fisher Scientific in a research note on Thursday, May 19th. Three equities research analysts have rated the stock with a hold rating and sixteen have assigned a buy rating to the company. The stock has an average rating of “Buy” and a consensus target price of $155.43.

The stock has a market cap of $60.85 billion and a PE ratio of 31.120. The stock has a 50-day moving average price of $149.93 and a 200-day moving average price of $141.50.

Thermo Fisher Scientific (NYSE:TMO) last posted its quarterly earnings results on Thursday, April 28th. The company reported $1.80 earnings per share (EPS) for the quarter, beating the Zacks’ consensus estimate of $1.74 by $0.06. During the same period last year, the firm posted $1.63 EPS. The firm had revenue of $4.29 billion for the quarter, compared to analysts’ expectations of $4.11 billion. Thermo Fisher Scientific’s revenue was up 9.6% on a year-over-year basis. Analysts expect that Thermo Fisher Scientific Inc. will post $8.13 earnings per share for the current fiscal year.

The company also recently declared a quarterly dividend, which will be paid on Monday, October 17th. Shareholders of record on Thursday, September 15th will be given a dividend of $0.15 per share. This represents a $0.60 dividend on an annualized basis and a yield of 0.39%. The ex-dividend date is Tuesday, September 13th.

In other Thermo Fisher Scientific news, CEO Marc N. Casper sold 20,000 shares of the business’s stock in a transaction dated Tuesday, July 5th. The stock was sold at an average price of $147.69, for a total transaction of $2,953,800.00. Following the transaction, the chief executive officer now owns 340,998 shares in the company, valued at $50,361,994.62. The sale was disclosed in a legal filing with the SEC, which is available at the SEC website. Also, SVP Thomas W. Loewald sold 15,000 shares of the business’s stock in a transaction dated Thursday, June 2nd. The stock was sold at an average price of $152.84, for a total value of $2,292,600.00. Following the transaction, the senior vice president now owns 49,169 shares in the company, valued at approximately $7,514,989.96. The disclosure for this sale can be found here.

Other hedge funds and institutional investors recently modified their holdings of the company. Haverford Trust Co. boosted its position in shares of Thermo Fisher Scientific by 0.5% in the fourth quarter. Haverford Trust Co. now owns 7,334 shares of the company’s stock worth $1,040,000 after buying an additional 34 shares in the last quarter. Cambridge Investment Research Advisors Inc. boosted its position in shares of Thermo Fisher Scientific by 16.2% in the fourth quarter. Cambridge Investment Research Advisors Inc. now owns 7,334 shares of the company’s stock worth $1,040,000 after buying an additional 1,022 shares in the last quarter. Ameritas Investment Partners Inc. boosted its position in shares of Thermo Fisher Scientific by 2.7% in the fourth quarter. Ameritas Investment Partners Inc. now owns 7,665 shares of the company’s stock worth $1,086,000 after buying an additional 204 shares in the last quarter. Bank of The Ozarks boosted its position in shares of Thermo Fisher Scientific by 5.4% in the fourth quarter. Bank of The Ozarks now owns 7,897 shares of the company’s stock worth $1,120,000 after buying an additional 408 shares in the last quarter. Finally, LMR Partners LLP bought a new position in shares of Thermo Fisher Scientific during the fourth quarter worth approximately $1,149,000.

Thermo Fisher Scientific Inc develops, manufactures and sells a range of products. The Company is a provider of analytical instruments, equipment, reagents and consumables, software and services for research, manufacturing, analysis, discovery and diagnostics. The company operates through four segments: Life Sciences Solutions, Analytical Instruments, Specialty Diagnostics, and Laboratory Products and Services.

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.